PROLOTHERAPY

Prolotherapy, as it is known today, was introduced by Dr George Stuart Hackett in the 1930s. In the first years it was known as sclerotherapy. In time, it was changed to "prolotherapy" due to the proliferation effect of the method. It was later popularised by physicians such as Gustav Hemwall.

In 1956 Dr Hackett published his work "Treatment of ligament and tendon relaxation by prolotherapy" and it became "The basic reference book in prolotherapy".

In 1969 the Hacket Hamwall Foundation was established. In 1992, Dr Jeffrey Patterson was appointed president of the same foundation and has continued to teach prolotherapy for more than forty years. Due to his contributions to the method, the foundation changed its name to HTTPF (Hackett-Hemwal-Patterson) and continues its activities today. This foundation is the oldest organisation providing prolotherapy training.

WHAT IS PROLOTHERAPY?

Mechanism of action of prolotherapy;
There was a repair and renewal mechanism existing in the human body to repair the damage that any tissue was exposed to for various reasons. This is called inflammation (inflammation).

All kinds of injuries and damages are repaired and renewed thanks to the chain of reactions called inflammation cascade. Acute inflammation is recognised in the case of new injuries and chronic inflammation in the case of old injuries. The aim of the prolotherapy technique is to create a controlled inflammation chamber in the tissue.

Accordingly, to initiate the regeneration process, the osmotic load created by dextrose (a kind of sugar) on the ground of micro trauma (small injury) created by the injection creates an aseptic (germ-free) inflammation in the injection site. In this process, the healing system in the body is activated and triggers the regeneration, repair and healing reaction. Infections are made especially in places where cells that act like stem cells that accumulate as tibroblasts in connective tissue are dense. Thus, on the one hand, connective tissue production is increased. On the other hand, the immune system (immune system) is stimulated and tissue regeneration is initiated.

Due to these mechanisms, the method is the most important instrument of regenerative medicine.

PRP, CGF or stem cells can be used as well as 15% Dextrose used in the treatment.

Prolotherapy by definition:: Various regenerative proliferative or irritant solutions are used in acute and chronic injuries of the locomotor system (musculoskeletal system), degenerative conditions (arthrosis), soft tissue pain, and joint and ligament laxity.

It is the name of the most effective method, particularly in cases of degeneration and obvious instability (non-fixed).

Where can it be applied?

When should it not be done?

Presence of infection in the area
Bleeding disorders
Allergy
Cancerous growth at the injection site
Rheumatic diseases
Patients non-compliant with treatment
Inflammation affecting the whole body
New fractures
Dislocations that have not been reset

Side Effects:

Pain at the injection site
Bruising, ecchymosis and haematoma
Increase in existing pain
Flu-like symptoms
Stiffness, numbness at the injection site
Syncope, hypotension (fainting)
Nausea
Hardness and swelling under the skin
Nerve damage